化学
小分子
药物发现
分子
选择性
组合化学
纳米技术
生物化学
有机化学
催化作用
材料科学
作者
Brigitt Raux,Karly Buchan,James M. Bennett,Thomas Christott,Matthew Dowling,Gillian Farnie,Oleg Fedorov,Vicki Gamble,C. Gileadi,Charline Giroud,K. Huber,Magdalena Korczynska,Chris Limberakis,Arjun Narayanan,Dafydd R. Owen,L. Diaz Saez,Ingrid A. Stock,Allyn T. Londregan
标识
DOI:10.1016/j.bmcl.2023.129546
摘要
Epigenetic proteins containing YEATS domains (YD) are an emerging target class in drug discovery. Described herein are the discovery and characterization efforts associated with PFI-6, a new chemical probe for the YD of MLLT1 (ENL/YEATS1) and MLLT3 (AF9/YEATS3). For hit identification, fragment-like mimetics of endogenous YD ligands (crotonylated histone-containing proteins), were synthesized via parallel medicinal chemistry (PMC) and screened for MLLT1 binding. Subsequent SAR studies led to iterative MLLT1/3 binding and selectivity improvements, culminating in the discovery of PFI-6. PFI-6 demonstrates good affinity and selectivity for MLLT1/3 vs. other human YD proteins (YEATS2/4) and engages MLLT3 in cells. Small-molecule X-ray co-crystal structures of two molecules, including PFI-6, bound to the YD of MLLT1/3 are also described. PFI-6 may be a useful tool molecule to better understand the biological effects associated with modulation of MLLT1/3.
科研通智能强力驱动
Strongly Powered by AbleSci AI